A new center for electron bio-imaging was officially opened by one of the three Nobel Prize winners.

It’s time for maternal health to move on from the dark ages, and pharma has a duty to help.

Sitting Down With…Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland

From big pharma, to cancer research to a fast growing CRO, James Hitchin has gained multiple perspectives on a subject that has become his passion – medicinal chemistry.

A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?

The automotive sector – Toyota, in particular – is a rich source of inspiration for improving productivity.

The development of an optimized bioprocess requires a holistic approach tailored to the specific needs of the product.

The fourth industrial revolution – Industry 4.0 – represents a shift in manufacturing mentality. Is biopharma ready?

CPhI Worldwide will return on October 9-11, 2018, at the IFEMA, Feria de Madrid, Spain.

“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.